Skip to main content
. 2022 Jun 10;7(3):100506. doi: 10.1016/j.esmoop.2022.100506

Figure 2.

Figure 2

Median overall survival for overall population, doublet, and triplet.

Bini, binimetinib; Cetux, cetuximab; CI, confidence interval; Enco, encorafenib; HR, hazard ratio; mOS, median overall survival; mos, months; mPFS, median progression-free survival; n, number.